Development of a consensus molecular classifier for pancreatic ductal adenocarcinoma

Abstract Background Pancreatic ductal adenocarcinoma (PDAC) presents a significant challenge, with a 5-year survival rate of approximately 10%. Tumor heterogeneity contributes to the limited effectiveness of treatments. Several tumor and stroma molecular classifiers have attempted to clarify this he...

Full description

Bibliographic Details

Main Authors:	Pablo Villoslada-Blanco, Lola Alonso, Sergio Sabroso-Lasa, Miguel Maquedano, Lidia Estudillo, Francisco X. Real, Evangelina López de Maturana, Núria Malats
Format:	Artigo
Language:	Inglês
Published:	BMC 2025-11-01
Series:	Genome Medicine
Subjects:	PDAC Consensus molecular classifier Transcriptomics Machine Learning Personalized medicine
Online Access:	https://doi.org/10.1186/s13073-025-01568-9
Tags:	Add Tag No Tags, Be the first to tag this record!